Literature DB >> 6105819

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

J M Cruickshank.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6105819     DOI: 10.1016/0002-8703(80)90112-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  47 in total

1.  Comparison of bisoprolol and diazepam in the treatment of cardiac neurosis.

Authors:  R Fogari; A Zoppi; L Corradi; C Pasotti; G D Malamani; R Gradnik; D Bokor; C Gala
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 2.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

Review 3.  Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  S G Lancaster; E M Sorkin
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.

Authors:  T Ban; S Sada; Y Takahashi; H Sada; T Fujita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

5.  Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.

Authors:  H Hallberg
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

6.  CNS-related side-effects with metoprolol and atenolol.

Authors:  J R Cove-Smith; C A Kirk
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Atenolol versus pindolol: side-effects in hypertension.

Authors:  E C Foerster; P Greminger; W Siegenthaler; H Vetter; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

9.  Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.

Authors:  V Hombach; V Braun; H W Höpp; D Gil-Sanchez; D W Behrenbeck; M Tauchert; H H Hilger
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.